Cancer Biomarkers Funding Opportunities
| Title | Announcement # |
Expiration Date |
|---|---|---|
| U.S.-China Program for Biomedical Collaborative Research |
RFA-CA-19-009 (R01 Clinical Trial Optional) [field_announcement_2] |
02/22/2019 |
| Mechanisms of Disparities in Chronic Liver Diseases and Cancer |
PAR-17-150 (R21) [field_announcement_2] |
04/05/2019 |
| Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection |
PAR-16-276 (R01) [field_announcement_2] |
06/14/2019 |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research |
RFA-CA-19-020 (R33 Clinical Trials Not Allowed) [field_announcement_2] |
09/28/2019 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research |
RFA-CA-19-019 (R21 Clinical Trials Not Allowed) [field_announcement_2] |
09/28/2019 |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research |
RFA-CA-19-021 (R21 Clinical Trials Not Allowed) [field_announcement_2] |
09/28/2019 |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research |
RFA-CA-19-022 (R33 Clinical Trials Not Allowed) [field_announcement_2] |
09/28/2019 |
| Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems |
PAR-18-009 (R01 Clinical Trial Optional) [field_announcement_2] |
11/06/2019 |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed |
PAR-18-310 [field_announcement_2] |
10/09/2020 |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed) |
PAR-18-317 [field_announcement_2] |
10/09/2020 |
| Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine |
PAR-18-841 (U24 - Clinical Trial Optional) [field_announcement_2] |
06/15/2021 |
| Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research |
PA-18-902 (R01 Clinical Trial Optional) [field_announcement_2] |
09/08/2021 |
| Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research |
PAR-19-113 (R01 Clinical Trial Optional) [field_announcement_2] |
01/08/2022 |